Sagimet Biosciences (SGMT) Change in Acquisitions & Divestments (2022 - 2026)

Sagimet Biosciences' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $17.0 million for Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 10.64% year-over-year to $17.0 million in Q1 2026; TTM through Mar 2026 was $109.4 million, a 75.34% increase from a year earlier, with the FY2025 full-year figure at $111.4 million, up 140.11% from the prior year.
• Change in Acquisitions & Divestments slipped to $17.0 million in Q1 2026 per SGMT's latest filing, from $31.4 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $31.4 million in Q4 2025 and bottomed at $3.0 million in Q1 2024.
• The 5-year median for Change in Acquisitions & Divestments is $18.0 million (2025), against an average of $17.7 million.
• Across the five-year window, Change in Acquisitions & Divestments slumped 84.54% in 2024 and surged 532.93% in 2025, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $5.4 million in 2022, then surged by 135.47% to $12.8 million in 2023, then surged by 84.44% to $23.6 million in 2024, then surged by 33.15% to $31.4 million in 2025, then sank by 46.02% to $17.0 million in 2026.
• Per Business Quant, the three latest SGMT Change in Acquisitions & Divestments figures stand at $17.0 million (Q1 2026), $31.4 million (Q4 2025), and $31.3 million (Q3 2025).